Aptamer Group is the developer of custom affinity tools for the life science industry through its proprietary Optimer® platform.
Optimer binders are affinity ligands that can be used as an antibody alternative to offer novel solutions and improvements to current processes across therapeutic, diagnostic, and research sectors.